{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:42:16Z","timestamp":1773182536155,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,20]]},"DOI":"10.7759\/cureus.18925","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:18:52Z","timestamp":1634739532000},"source":"Crossref","is-referenced-by-count":13,"title":["Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms"],"prefix":"10.7759","author":[{"given":"Susmita","family":"Unni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen J","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satesh","family":"Bidaisee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy FD","year":"1998","unstructured":"Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998, 339:520-32. 10.1056\/NEJM199808203390806","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Investigation and control of vancomycin-resistant Staphylococcus aureus (VRSA)","author":"Walters M","year":"2015","unstructured":"Walters M, Lonsway D, Rasheed K,  Albrecht V, McAllister S, Limbago B, Kallen A. Investigation and control of vancomycin-resistant Staphylococcus aureus (VRSA). Centers for Disease Control and Prevention, Atlanta, GA; 2015."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.30","article-title":"Genetics of antimicrobial resistance in Staphylococcus aureus","volume":"4","author":"Jensen SO","year":"2009","unstructured":"Jensen SO, Lyon BR. Genetics of antimicrobial resistance in Staphylococcus aureus. Future Microbiol. 2009, 4:565-82. 10.2217\/fmb.09.30","journal-title":"Future Microbiol"},{"key":"ref4","article-title":"Vancomycin resistance in Staphylococcus aureus","volume":"90","author":"McGuinness WA","year":"2017","unstructured":"McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus\u2029. Yale J Biol Med. 2017, 90:269-81.","journal-title":"Yale J Biol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/jb.158.2.513-516.1984","article-title":"Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus","volume":"158","author":"Hartman BJ","year":"1984","unstructured":"Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984, 158:513-6. 10.1128\/jb.158.2.513-516.1984","journal-title":"J Bacteriol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1323-1336.2001","article-title":"Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus","volume":"45","author":"Ito T","year":"2001","unstructured":"Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001, 45:1323-36. 10.1128\/AAC.45.5.1323-1336.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2637-2651.2004","article-title":"Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC","volume":"48","author":"Ito T","year":"2004","unstructured":"Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004, 48:2637-51. 10.1128\/AAC.48.7.2637-2651.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1147-1152.2002","article-title":"Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains","volume":"46","author":"Ma XX","year":"2002","unstructured":"Ma XX, Ito T, Tiensasitorn C, et al.. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002, 46:1147-52. 10.1128\/AAC.46.4.1147-1152.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00346-09","article-title":"VanA-type vancomycin-resistant Staphylococcus aureus","volume":"53","author":"P\u00e9richon B","year":"2009","unstructured":"P\u00e9richon B, Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009, 53:4580-7. 10.1128\/AAC.00346-09","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01587-12","article-title":"pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro","volume":"57","author":"Zhu W","year":"2013","unstructured":"Zhu W, Clark N, Patel JB. pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro. Antimicrob Agents Chemother. 2013, 57:212-9. 10.1128\/AAC.01587-12","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu K","year":"1997","unstructured":"Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997, 40:135-6. 10.1093\/jac\/40.1.135","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati A","year":"2020","unstructured":"Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep. 2020, 10:12689. 10.1038\/s41598-020-69058-z","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith TL","year":"1999","unstructured":"Smith TL, Pearson ML, Wilcox KR, et al.. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999, 340:493-501. 10.1056\/NEJM199902183400701","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00422-06","article-title":"Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"50","author":"Howden BP","year":"2006","unstructured":"Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006, 50:3039-47. 10.1128\/AAC.00422-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400704","article-title":"The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection","volume":"340","author":"Sieradzki K","year":"1999","unstructured":"Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med. 1999, 340:517-23. 10.1056\/NEJM199902183400704","journal-title":"N Engl J Med"},{"key":"ref16","article-title":"Investigation and control of vancomycin-resistant Staphylococcus aureus (VRSA)","author":"Walters M","year":"2015","unstructured":"Walters M, Lonsway D, Rasheed K, Albrecht V, McAllister S, Limbago B, Kallen A. Investigation and control of vancomycin-resistant Staphylococcus aureus (VRSA). Centers for Disease Control and Prevention, Atlanta, GA; 2015."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu C","year":"2003","unstructured":"Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003, 47:3040-5. 10.1128\/AAC.47.10.3040-3045.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02187-13","article-title":"Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States","volume":"52","author":"Limbago BM","year":"2014","unstructured":"Limbago BM, Kallen AJ, Zhu W, Eggers P, McDougal LK, Albrecht VS. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. J Clin Microbiol. 2014, 52:998-1002. 10.1128\/JCM.02187-13","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","author":"McDougal LK","year":"2003","unstructured":"McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003, 41:5113-20. 10.1128\/JCM.41.11.5113-5120.2003","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.2.199","article-title":"Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50","volume":"42","author":"Hanaki H","year":"1998","unstructured":"Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998, 42:199-209. 10.1093\/jac\/42.2.199","journal-title":"J Antimicrob Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2276-2285.2000","article-title":"Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50","volume":"44","author":"Cui L","year":"2000","unstructured":"Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother. 2000, 44:2276-85. 10.1128\/AAC.44.9.2276-2285.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel LM","year":"2003","unstructured":"Weigel LM, Clewell DB, Gill SR, et al.. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003, 302:1569-71. 10.1126\/science.1090956","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3954-3959.2003","article-title":"Plasmid content of a vancomycin-resistant Enterococcus faecalis isolate from a patient also colonized by Staphylococcus aureus with a VanA phenotype","volume":"47","author":"Flannagan SE","year":"2003","unstructured":"Flannagan SE, Chow JW, Donabedian SM, et al.. Plasmid content of a vancomycin-resistant Enterococcus faecalis isolate from a patient also colonized by Staphylococcus aureus with a VanA phenotype. Antimicrob Agents Chemother. 2003, 47:3954-9. 10.1128\/AAC.47.12.3954-3959.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.275-280.2004","article-title":"Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania","volume":"48","author":"Tenover FC","year":"2004","unstructured":"Tenover FC, Weigel LM, Appelbaum PC, et al.. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2004, 48:275-80. 10.1128\/AAC.48.1.275-280.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00576-06","article-title":"High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm","volume":"51","author":"Weigel LM","year":"2007","unstructured":"Weigel LM, Donlan RM, Shin DH, et al.. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother. 2007, 51:231-8. 10.1128\/AAC.00576-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00908-07","article-title":"Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan","volume":"52","author":"Zhu W","year":"2008","unstructured":"Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother. 2008, 52:452-7. 10.1128\/AAC.00908-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3201\/eid1506.081312","article-title":"Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007","volume":"15","author":"Finks J","year":"2009","unstructured":"Finks J, Wells E, Dyke TL, et al.. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis. 2009, 15:943-5. 10.3201\/eid1506.081312","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","volume":"21","author":"Cong Y","year":"2020","unstructured":"Cong Y, Yang S, Rao X. Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res. 2020, 21:169-76. 10.1016\/j.jare.2019.10.005","journal-title":"J Adv Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6437a6","article-title":"Vancomycin-resistant Staphylococcus aureus - Delaware, 2015","volume":"64","author":"Walters MS","year":"2015","unstructured":"Walters MS, Eggers P, Albrecht V, et al.. Vancomycin-resistant Staphylococcus aureus - Delaware, 2015. MMWR Morb Mortal Wkly Rep. 2015, 64:1056. 10.15585\/mmwr.mm6437a6","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-156","article-title":"Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India","volume":"6","author":"Tiwari HK","year":"2006","unstructured":"Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. 2006, 6:156. 10.1186\/1471-2334-6-156","journal-title":"BMC Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47144-0","article-title":"Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia)","volume":"57","author":"Saha B","year":"2008","unstructured":"Saha B, Singh AK, Ghosh A, Bal M. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol. 2008, 57:72-9. 10.1099\/jmm.0.47144-0","journal-title":"J Med Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1159\/000141513","article-title":"Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran","volume":"17","author":"Aligholi M","year":"2008","unstructured":"Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract. 2008, 17:432-4. 10.1159\/000141513","journal-title":"Med Princ Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.91001","article-title":"Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad","volume":"134","author":"Thati V","year":"2011","unstructured":"Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011, 134:704-8. 10.4103\/0971-5916.91001","journal-title":"Indian J Med Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/jobm.201000221","article-title":"Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus","volume":"51","author":"Mirani ZA","year":"2011","unstructured":"Mirani ZA, Jamil N. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. J Basic Microbiol. 2011, 51:191-5. 10.1002\/jobm.201000221","journal-title":"J Basic Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2014.90","article-title":"VanA and VanB positive vancomycin-resistant Staphylococcus aureus among clinical isolates in Shiraz, South of Iran","volume":"29","author":"Saadat S","year":"2014","unstructured":"Saadat S, Solhjoo K, Norooz-Nejad MJ, Kazemi A. VanA and VanB positive vancomycin-resistant Staphylococcus aureus among clinical isolates in Shiraz, South of Iran. Oman Med J. 2014, 29:335-9. 10.5001\/omj.2014.90","journal-title":"Oman Med J"},{"key":"ref36","article-title":"Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer","volume":"15","author":"Dezfulian A","year":"2012","unstructured":"Dezfulian A, Aslani MM, Oskoui M, et al.. Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iran J Basic Med Sci. 2012, 15:803-6.","journal-title":"Iran J Basic Med Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183607","article-title":"Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: a three year study in Tehran, Iran","volume":"12","author":"Shekarabi M","year":"2017","unstructured":"Shekarabi M, Hajikhani B, Salimi Chirani A, Fazeli M, Goudarzi M. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: a three year study in Tehran, Iran. PLoS One. 2017, 12:e0183607. 10.1371\/journal.pone.0183607","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14357","article-title":"Vancomycin-resistant Staphylococcus aureus infection post-liposuction in South Korea","volume":"13","author":"Nelwan EJ","year":"2021","unstructured":"Nelwan EJ, Andayani D, Clarissa G, Pramada T. Vancomycin-resistant Staphylococcus aureus infection post-liposuction in South Korea. Cureus. 2021, 13:e14357. 10.7759\/cureus.14357","journal-title":"Cureus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.9734\/AIR\/2014\/7142","article-title":"Prevalence and conjugal transfer of vancomycin resistance among clinical isolates of Staphylococcus aureus","volume":"2","author":"Abd El-Baky RM","year":"2013","unstructured":"Abd El-Baky RM, Ahmed HR, Gad GF. Prevalence and conjugal transfer of vancomycin resistance among clinical isolates of Staphylococcus aureus. Adv Res. 2013, 2:12-23. 10.9734\/AIR\/2014\/7142","journal-title":"Adv Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2018.00003","article-title":"Phenotypic and molecular identification of vancomycin resistance in clinical Staphylococcus aureus isolates in Osogbo, Nigeria","volume":"8","author":"Bamigboye BT","year":"2018","unstructured":"Bamigboye BT, Olowe OA, Taiwo SS. Phenotypic and molecular identification of vancomycin resistance in clinical Staphylococcus aureus isolates in Osogbo, Nigeria. Eur J Microbiol Immunol (Bp). 2018, 8:25-30. 10.1556\/1886.2018.00003","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303359","article-title":"Transferable vancomycin resistance in a community-associated MRSA lineage","volume":"370","author":"Rossi F","year":"2014","unstructured":"Rossi F, Diaz L, Wollam A, et al.. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med. 2014, 370:1524-31. 10.1056\/NEJMoa1303359","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61219-2","article-title":"First case of infection with vancomycin-resistant Staphylococcus aureus in Europe","volume":"382","author":"Melo-Cristino J","year":"2013","unstructured":"Melo-Cristino J, Resina C, Manuel V, Lito L, Ramirez M. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet. 2013, 382:205. 10.1016\/S0140-6736(13)61219-2","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.10.3879-3881.2000","article-title":"Vancomycin-intermediate Staphylococcus aureus in Korea","volume":"38","author":"Kim MN","year":"2000","unstructured":"Kim MN, Pai CH, Woo JH, Ryu JS, Hiramatsu K. Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol. 2000, 38:3879-81. 10.1128\/JCM.38.10.3879-3881.2000","journal-title":"J Clin Microbiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00954-09","article-title":"First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia","volume":"48","author":"Al-Obeid S","year":"2010","unstructured":"Al-Obeid S, Haddad Q, Cherkaoui A, Schrenzel J, Fran\u00e7ois P. First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. J Clin Microbiol. 2010, 48:2199-204. 10.1128\/JCM.00954-09","journal-title":"J Clin Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)79166-2","article-title":"First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital","volume":"351","author":"Ploy MC","year":"1998","unstructured":"Ploy MC, Gr\u00e9laud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet. 1998, 351:1212. 10.1016\/s0140-6736(05)79166-2","journal-title":"Lancet"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050380","article-title":"Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany","volume":"18","author":"Bierbaum G","year":"1999","unstructured":"Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis. 1999, 18:691-6. 10.1007\/s100960050380","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73709-reduced-susceptibility-and-resistance-to-vancomycin-of-staphylococcus-aureus-a-review-of-global-incidence-patterns-and-related-genetic-mechanisms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:31Z","timestamp":1707507091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73709-reduced-susceptibility-and-resistance-to-vancomycin-of-staphylococcus-aureus-a-review-of-global-incidence-patterns-and-related-genetic-mechanisms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.18925","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}